GGrantIndex
Sort

21,281 grants matching influenza

Dynamics of the protective vaccine-induced human influenza neuraminidase B cell response

$759,187
James J Kobie · University Of Alabama At Birmingham · R01 · FY2022 · AI

B-cell repertoire analysis in influenza vaccination and infection

$759,032
Hua-Xin Liao · Boston Children'S Hospital · P01 · FY2012 · AI

Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy

$758,985
Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA

Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy

$758,985
Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA

Elucidating the functions of red blood cell factors in malaria parasite invasion

$758,965
Elizabeth S. Egan · Stanford University · R01 · FY2023 · HL

Cellular and molecular programming of lung resident T cell memory

$758,832
Jacob E Kohlmeier · Emory University · R35 · FY2024 · HL

Perturbing the HIV Reservoir with Immune Stimulation

$758,807
David Mitchell Smith · University Of California, San Diego · R01 · FY2018 · AI

Immune response to COVID-19 vaccine in HIV infected men and women

$758,692
Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI

Systems Pathogenomics of Severe Acute Respiratory Virus Infection

$758,603
Ralph S Baric · Oregon Health & Science University · U54 · FY2011 · AI

Molecular Basis for the TREX-2 mRNA Nuclear Export Pathway

$758,594
Beatriz Marina Avila Fontoura · Ut Southwestern Medical Center · R01 · FY2025 · GM

Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines

$758,514
Xiufeng Henry Wan · University Of Missouri-Columbia · R01 · FY2020 · AI

Selecting HA glycosylation for improved vaccine responses

$758,441
Joseph Zaia · Boston University Medical Campus · R01 · FY2025 · AI

Effects of a Novel, Scalable, and Sustainable Patient Portal Intervention on Diabetes-Related Outcomes: A Pragmatic Randomized Controlled Trial

$758,334
William Martinez · Vanderbilt University Medical Center · R01 · FY2023 · DK

Dynamics of the protective vaccine-induced human influenza neuraminidase B cell response

$758,319
James J Kobie · University Of Alabama At Birmingham · R01 · FY2021 · AI

Impact of selective genome packaging on influenza A virus reassortment

$758,097
Anice C Lowen · Emory University · R01 · FY2018 · AI

Production and Characterization of Human Immunoglobulin Producing Goats for Diagnostic Reagents and Therapeutics

$758,090
Hua Wu · Sab Capra, Llc · R42 · FY2019 · AI

Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort

$758,055
Scott Dexter Boyd · Stanford University · R01 · FY2017 · AI

Dynamics of the protective vaccine-induced human influenza neuraminidase B cell response

$757,938
James J Kobie · University Of Alabama At Birmingham · R01 · FY2020 · AI

Perturbing the HIV Reservoir with Immune Stimulation

$757,905
David Mitchell Smith · University Of California, San Diego · R01 · FY2019 · AI

Development of novel isoflavone drugs as broad spectrum antivirals

$757,817
Kristin M Bedard · Kineta, Inc. · R44 · FY2016 · AI

Pittsburgh Influenza Prevention Project

$757,742
Donald S. Burke · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · CI

Pittsburgh Influenza Prevention Project

$757,742
Donald S. Burke · University Of Pittsburgh At Pittsburgh · U01 · FY2006 · CI

Collaborative IVR Platform for Multilingual Patient Outreach and Education

$757,714
William Z Tan · Transcendent International, Llc · R44 · FY2009 · DK

Central role of Caspase-8 in control of host tolerance and resistance mechanisms in pulmonary macrophage populations during severe respiratory infections

$757,662
Amanda M Jamieson · Brown University · R01 · FY2024 · HL

Transcriptomic Signatures of Influenza Vaccine Responses

$757,630
Gregory A. Poland · Mayo Clinic Rochester · R01 · FY2022 · AI